TY - JOUR T1 - Increased SAR-CoV-2 shedding associated with reduced disease severity despite continually emerging genetic variants JF - medRxiv DO - 10.1101/2021.02.03.21250928 SP - 2021.02.03.21250928 AU - Cynthia Y. Tang AU - Yang Wang AU - Cheng Gao AU - David R. Smith AU - Jane A. McElroy AU - Tao Li AU - Karen Segovia AU - Tricia Haynes AU - Richard Hammer AU - Christopher Sampson AU - Detlef Ritter AU - Christopher Schulze AU - Robin Trotman AU - Grace M Lidl AU - Richard Webby AU - Jun Hang AU - Xiu-Feng Wan Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/05/2021.02.03.21250928.abstract N2 - Since the first report of SARS-CoV-2 in December 2019, genetic variants have continued to emerge, complicating strategies for mitigating the disease burden of COVID-19. Positive SARS-CoV-2 nasopharyngeal swabs (n=8,735) were collected from Missouri, USA, from March-October 2020, and viral genomes (n=178) were sequenced. Hospitalization status and length of stay were extracted from medical charts of 1,335 patients and integrated with emerging genetic variants and viral shedding analyses for assessment of clinical impacts. Multiple introductions of SARS-CoV-2 into Missouri, primarily from Australia, Europe, and domestic states, were observed. Four local lineages rapidly emerged and spread across urban and rural regions in Missouri. While the majority of Missouri viruses harbored Spike-D614G mutations, a large number of unreported mutations were identified among Missouri viruses, including seven in the RNA-dependent RNA polymerase complex and Spike protein that were positively selected. A 15.6-fold increase in viral RNA levels in swab samples occurred from March to May and remained elevated. Accounting for other comorbidities, individuals test-positive for COVID-19 with high viral loads were less likely to be hospitalized (odds ratio=0.39, 95% confidence interval [CI]=0.20, 0.77) and had shorter hospital stays (hazard ratio=0.34, p=0.003) than those with low viral loads. Overall, the first eight months of the pandemic in Missouri saw multiple locally acquired mutants emerge and dominate in urban and rural locations. Although we were unable to find associations between specific variants and greater disease severity, Missouri COVID-positive individuals that presented with increased viral shedding had less severe disease by several measures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementCynthia Tang is supported by NIH 5T32LM012410. Global Emerging Infections Surveillance Branch of the Armed Forces Health Surveillance Division (ProMIS ID P0140_20_WR_01.Global).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the University of Missouri Institutional Review Board (#2025449).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesGenome data may be accessed using GenBank Accession Numbers: MW004168, MW521383-MW521516, MW525282.  ER -